Divalproex Sodium Tablet, Delayed Release
Product Images NDC 68788-8609

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 68788-8609). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-divalproex-figure-1 (Spl Divalproex Figure 1)

This text appears to list different studies labeled as Study 1 and Study 2, involving PBO and DVPX. Study 1 likely involves the "Young Mania Rating Scale (YMRS)", while Study 2 potentially uses the "Mania Rating Scale (MRS)". These studies may be comparing the effects or efficacy of PBO and DVPX in specific contexts.*

FDA Label Image

Spl-divalproex-figure-2 (Spl Divalproex Figure 2)

This text appears to be showing a diagram illustrating the impact of different rates of reduction in CPS (presumably chronic pain syndrome) on patients, with percentages ranging from -100% to 100%. The diagram compares the effects of DVPX medication versus placebo on a group of patients, showing the percentage of patients experiencing improvement, no change, or worsening. The diagram provides a visual representation of the effectiveness of the medication in reducing CPS rates.*

FDA Label Image

Spl-divalproex-figure-3 (Spl Divalproex Figure 3)

FDA Label Image

Spl-divalproex-figure-4 (Spl Divalproex Figure 4)

This text describes a comparison of mean 4-week migraine rates between a placebo and DVPX in two studies. The data is presented in Figure 4.*

FDA Label Image

Divalproex Sodium Dr 250mg (Spl Divalproex Label 250mg)

This is a description of Divalproex Sodium DR 250, a generic version of Depakote DR used for epilepsy and bipolar disorder. The medication comes in enteric-coated tablets containing Divalproex sodium equivalent to 250mg valproic acid. It should be stored at a temperature of 20°C to 25°C and is oval, orange, with specific imprints. The information also includes details about the manufacturer, precautions, warnings, and instructions for use.*

FDA Label Image

Spl-divalproex-structure (Spl Divalproex Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.